Poglitsch, M
~ 200  results:
Search for persons X
?
1

A novel SGLT-2 score to identify HFpEF patients who may ben..:

Binder, C ; Poglitsch, M ; Rettl, R.R...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
2

Role of angiotensin peptides in risk stratification and pro..:

Wang, K ; Basu, R ; Poglitsch, M..
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
3

Comparison between the effects of torsemide and furosemide ..:

Potter, B.M. ; Ames, M.K. ; Hess, A..
Journal of Veterinary Cardiology.  26 (2019)  - p. 51-62 , 2019
 
?
4

P1661The myocardial tissue Renin-Angiotensin-System (RAS) o..:

Pavo, N ; Arfsten, H ; Wurm, R...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
5

P5448Enzymatic regulation of the myocardial tissue renin-an..:

Arfsten, H ; Pavo, N ; Wurm, R...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
 
?
 
?
 
?
10

Quantification of systemic renin-angiotensin system peptide..:

van Rooyen, JM ; Poglitsch, M ; Huisman, HW...
Journal of the Renin-Angiotensin-Aldosterone System.  17 (2016)  4 - p. 147032031666988 , 2016
 
?
12

CMV Late Phase-Induced mTOR Activation Is Essential for Eff..:

Poglitsch, M. ; Weichhart, T. ; Hecking, M....
American Journal of Transplantation.  12 (2012)  6 - p. 1458-1468 , 2012
 
?
14

The Novel Immunosuppressant FK778 Inhibits Formation of the..:

Zeyda, M. ; Geyeregger, R. ; Poglitsch, M....
Transplantation Proceedings.  37 (2005)  4 - p. 1970-1971 , 2005
 
?
15

No evidence for brain renin-angiotensin system activation d..:

Uijl, Estrellita ; Ren, Liwei ; Colafella, KMM...
Uijl , E , Ren , L , Colafella , KMM , van Veghel , R , Van den Berg - Garrelds , I , Domenig , O , Poglitsch , M , Zlatev , I , Kim , JB , Huang , S , Melton , L , Hoorn , E , Foster , D & Danser , AHJ 2021 , ' No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension ' , Clinical Science , vol. 135 , no. 2 , pp. 259-274 . https://doi.org/10.1042/cs20201239.  , 2021
 
1-15